Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

aemetis inc - AMTX

AMTX

Close Chg Chg %
2.98 0.18 6.04%

Closed Market

3.16

+0.18 (6.04%)

Volume: 2.10M

Last Updated:

Apr 2, 2026, 4:00 PM EDT

Trade Now

Company Overview: aemetis inc - AMTX

AMTX Key Data

Open

$2.98

 Day Range

2.90 - 3.23

52 Week Range

1.22 - 3.66

 Market Cap

$210.56M

Shares Outstanding

66.63M

 Public Float

61.89M

Beta

1.48

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$1.33

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

2.08M

  

AMTX Performance

1 Week
 
 -4.24%
 
1 Month
 
 125.71%
 
3 Months
 
 98.74%
 
1 Year
 
 100.63%
 
5 Years
 
 -87.92%
 

AMTX Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 3
Full Ratings ➔

About aemetis inc - AMTX

Aemetis, Inc. is a renewable fuels and biochemical company, which engages in the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products. It operates through the North America and India geographical segments. The North America segment manages Keyes Plant in California, the cellulosic ethanol facility in Riverbank, the cluster of biogas digesters on dairies near Keyes, California, the Goodland Plant, Kansas and the research and development facility in Minnesota. The India segment refers to the Kakinada plant, administrative offices in Hyderabad, and holding companies in Nevada and Mauritius. Its products include glycerin, ethanol, food and feed, biodiesel, and edible oils. The company was founded by Eric Armstrong McAfee in 2006 and is headquartered in Cupertino, CA.

AMTX At a Glance

Aemetis, Inc.
20400 Stevens Creek Boulevard
Cupertino, California 95014
Phone 1-408-213-0940 Revenue 207.98M
Industry Chemicals: Specialty Net Income -77,001,000.00
Sector Process Industries Employees 220
Fiscal Year-end 12 / 2026
View SEC Filings

AMTX Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.401
Price to Book Ratio N/A
Price to Cash Flow Ratio 25.55
Enterprise Value to EBITDA -21.934
Enterprise Value to Sales 2.849
Total Debt to Enterprise Value 0.868

AMTX Efficiency

Revenue/Employee 945,368.182
Income Per Employee -350,004.545
Receivables Turnover 429.713
Total Asset Turnover 0.801

AMTX Liquidity

Current Ratio 0.072
Quick Ratio 0.041
Cash Ratio 0.013

AMTX Profitability

Gross Margin -0.369
Operating Margin -17.895
Pretax Margin -46.037
Net Margin -37.023
Return on Assets -29.665
Return on Equity N/A
Return on Total Capital -37.152
Return on Invested Capital -4,778.219

AMTX Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 248.044
Total Debt to Total Assets 197.847
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 94.286
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Aemetis Inc - AMTX

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
256.51M 186.72M 267.64M 207.98M
Sales Growth
+21.03% -27.21% +43.34% -22.29%
Cost of Goods Sold (COGS) incl D&A
262.05M 184.70M 268.22M 208.75M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
5.88M 7.30M 8.94M 10.20M
Depreciation
5.83M 7.23M 8.90M 10.16M
Amortization of Intangibles
46.00K 72.00K 46.00K 46.00K
COGS Growth
+28.45% -29.52% +45.22% -22.17%
Gross Income
(5.54M) 2.02M (580.00K) (768.00K)
Gross Income Growth
-169.72% +136.44% -128.76% -32.41%
Gross Profit Margin
-2.16% +1.08% -0.22% -0.37%
2022 2023 2024 2025 5-year trend
SG&A Expense
28.87M 39.42M 39.84M 36.45M
Research & Development
- - 180.00K 152.00K
-
Other SG&A
28.69M 39.27M 39.84M 36.45M
SGA Growth
+21.47% +36.56% +1.06% -8.50%
Other Operating Expense
- - - -
-
Unusual Expense
- - - 47.99M
-
EBIT after Unusual Expense
(82.39M) (37.40M) (40.42M) (37.22M)
Non Operating Income/Expense
14.34M 2.08M 1.37M 2.61M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
38.66M 64.83M 59.32M 61.14M
Interest Expense Growth
+21.66% +67.71% -8.50% +3.07%
Gross Interest Expense
49.76M 70.43M 64.32M 65.24M
Interest Capitalized
11.10M 5.60M 5.00M 4.10M
Pretax Income
(106.70M) (100.16M) (98.37M) (95.75M)
Pretax Income Growth
-125.71% +6.14% +1.78% +2.66%
Pretax Margin
-41.60% -53.64% -36.75% -46.04%
Income Tax
1.05M (53.74M) (10.83M) (18.75M)
Income Tax - Current - Domestic
13.00K (55.15M) (12.26M) (18.01M)
Income Tax - Current - Foreign
230.00K 1.49M 1.47M 235.00K
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
810.00K (74.00K) (41.00K) (969.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(107.76M) (46.42M) (87.54M) (77.00M)
Minority Interest Expense
- - - -
-
Net Income
(107.76M) (46.42M) (87.54M) (77.00M)
Net Income Growth
-128.56% +56.92% -88.58% +12.04%
Net Margin Growth
-42.01% -24.86% -32.71% -37.02%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(107.76M) (46.42M) (87.54M) (77.00M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(107.76M) (46.42M) (87.54M) (77.00M)
EPS (Basic)
-3.1157 -1.2196 -1.907 -1.2837
EPS (Basic) Growth
-102.77% +60.86% -56.36% +32.68%
Basic Shares Outstanding
34.59M 38.06M 45.90M 59.98M
EPS (Diluted)
-3.1157 -1.2196 -1.907 -1.2837
EPS (Diluted) Growth
-102.77% +60.86% -56.36% +32.68%
Diluted Shares Outstanding
34.59M 38.06M 45.90M 59.98M
EBITDA
(28.52M) (30.10M) (31.47M) (27.02M)
EBITDA Growth
-186.80% -5.54% -4.55% +14.16%
EBITDA Margin
-11.12% -16.12% -11.76% -12.99%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 10.75
Number of Ratings 3 Current Quarters Estimate -0.25
FY Report Date 06 / 2026 Current Year's Estimate -0.997
Last Quarter’s Earnings -0.182 Median PE on CY Estimate N/A
Year Ago Earnings -1.28 Next Fiscal Year Estimate -0.307
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 3 3
Mean Estimate -0.25 -0.25 -1.00 -0.31
High Estimates -0.12 -0.12 -0.42 -0.08
Low Estimate -0.49 -0.49 -1.97 -0.51
Coefficient of Variance -83.31 -85.34 -85.05 -70.43

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 2 2 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Aemetis Inc - AMTX

Date Name Shares Transaction Value
Jun 11, 2025 Timothy Alan Simon Director 45,261 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $1.98 per share 89,616.78
Jun 11, 2025 Timothy Alan Simon Director 40,632 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $1.98 per share 80,451.36
Jun 11, 2025 Timothy Alan Simon Director 50,261 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $1.98 per share 99,516.78
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 1,105,701 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 1,113,236 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 1,149,998 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 1,219,998 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 1,249,998 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 1,312,498 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 1,339,582 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 1,344,582 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 456,821 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.86 per share 392,866.06
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 449,286 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.7 per share 314,500.20
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 412,524 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.7 per share 288,766.80
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 342,524 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.67 per share 229,491.08
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 312,524 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.6 per share 187,514.40
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 250,024 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.92 per share 230,022.08
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 222,940 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $1.71 per share 381,227.40
Apr 9, 2025 Todd A. Waltz Executive Vice President, CFO 217,940 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $0.7 per share 152,558.00

Aemetis Inc in the News